BioCorRx Inc. (BICX) financial statements (2020 and earlier)
Company profile
| Business Address |
2390 EAST ORANGEWOOD AVENUE ANAHEIM, CA 92806 |
| State of Incorp. | |
| Fiscal Year End | December 31 |
| SIC | 8093 - Specialty Outpatient Facilities, Not Elsewhere Classified (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in millions)
| 12/31/2019 Q4 | 9/30/2019 Q3 | 6/30/2019 Q2 | 3/31/2019 Q1 | 12/31/2018 Q4 | 9/30/2018 Q3 | 6/30/2018 Q2 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 3 | 4 | 5 | 0 | 0 | 0 | 1 | ||
| Cash and cash equivalents | 3 | 4 | 5 | 0 | 0 | 0 | 1 | ||
| Prepaid expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Other undisclosed current assets | 0 | 0 | (0) | 0 | 0 | 0 | |||
| Total current assets: | 3 | 4 | 5 | 0 | 0 | 0 | 1 | ||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 0 | 0 | ✕ | ✕ | ✕ | ||||
| Property, plant and equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Long-term investments and receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Long-term investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Intangible assets, net (including goodwill) | 0 | 0 | 0 | 0 | 0 | ||||
| Intangible assets, net (excluding goodwill) | 0 | 0 | 0 | 0 | 0 | ||||
| Other undisclosed noncurrent assets | 0 | 0 | 1 | 0 | 0 | 0 | 0 | ||
| Total noncurrent assets: | 1 | 1 | 1 | 0 | 0 | 0 | 0 | ||
| TOTAL ASSETS: | 4 | 4 | 6 | 0 | 1 | 1 | 1 | ||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 2 | 2 | 2 | 2 | 2 | 1 | 1 | ||
| Accounts payable | 1 | 0 | 0 | 1 | 1 | 1 | 1 | ||
| Interest and dividends payable | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||
| Other undisclosed accounts payable and accrued liabilities | 0 | 0 | 0 | 0 | 0 | ||||
| Deferred revenue | 0 | 0 | ✕ | ✕ | ✕ | ||||
| Debt | (0) | 0 | 1 | 1 | 1 | 0 | 0 | ||
| Due to related parties | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Deferred revenue and credits | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 0 | ||
| Other undisclosed current liabilities | 0 | 0 | 4 | 4 | 4 | 3 | 3 | ||
| Total current liabilities: | 3 | 2 | 7 | 7 | 6 | 5 | 5 | ||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 0 | 0 | |||||||
| Operating lease, liability | 0 | 0 | ✕ | ✕ | ✕ | ||||
| Liabilities, other than long-term debt, including: | 0 | 0 | 0 | 0 | 0 | ||||
| Deferred revenue and credits | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 0 | ||
| Deferred revenue | 0 | 0 | ✕ | ✕ | ✕ | ||||
| Other undisclosed liabilities, other than long-term debt | 0 | 0 | |||||||
| Other undisclosed noncurrent liabilities | 2 | 2 | (6) | 0 | |||||
| Total noncurrent liabilities: | 2 | 2 | (6) | 0 | 0 | 0 | 0 | ||
| Total liabilities: | 5 | 4 | 0 | 7 | 6 | 5 | 5 | ||
| Commitments and contingencies | 9 | ||||||||
| Temporary equity, carrying amount | (0) | ||||||||
| Stockholders' equity | |||||||||
| Stockholders' equity attributable to parent, including: | (1) | 0 | (3) | (6) | (6) | (5) | (4) | ||
| Preferred stock | 0 | 0 | 0 | 0 | |||||
| Common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Common stock, value, subscriptions | 0 | 0 | 0 | 0 | 0 | 0 | 1 | ||
| Additional paid in capital | 60 | 60 | 56 | 52 | 49 | 47 | 45 | ||
| Accumulated deficit | (61) | (60) | (59) | (57) | (55) | (53) | (51) | ||
| Other undisclosed stockholders' equity attributable to parent | (0) | (0) | (0) | (2) | (0) | 0 | 0 | ||
| Stockholders' equity attributable to noncontrolling interest | (0) | (0) | |||||||
| Other undisclosed stockholders' equity | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Total stockholders' equity: | (1) | 0 | (3) | (6) | (6) | (5) | (4) | ||
| Other undisclosed liabilities and equity | (0) | (0) | (0) | (0) | (0) | (0) | |||
| TOTAL LIABILITIES AND EQUITY: | 4 | 4 | 6 | 0 | 1 | 1 | 1 | ||
Income statement (P&L) ($ in millions)
| 12/31/2019 Q4 | 9/30/2019 Q3 | 6/30/2019 Q2 | 3/31/2019 Q1 | 12/31/2018 Q4 | 9/30/2018 Q3 | 6/30/2018 Q2 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Financial services revenue | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 0 | |
| Cost of revenue | (0) | (0) | (0) | (0) | (0) | (0) | (0) | |
| Gross profit: | 0 | 0 | 0 | 0 | (0) | 0 | 0 | |
| Operating expenses | (2) | (1) | (2) | (2) | (5) | |||
| Other undisclosed operating income | 0 | 0 | 0 | 0 | 0 | |||
| Operating income (loss): | (2) | (1) | (2) | (1) | (5) | 0 | 0 | |
| Nonoperating income (expense) | 0 | (0) | (0) | (0) | (2) | |||
| Interest and debt expense | (0) | 0 | (1) | (1) | 1 | (0) | (0) | |
| Net loss: | (2) | (1) | (3) | (2) | (5) | (0) | (0) | |
| Net income (loss) attributable to noncontrolling interest | 1 | 1 | 2 | 2 | 11 | (2) | 1 | |
| Other undisclosed net income (loss) attributable to parent | (1) | (1) | (1) | (1) | (8) | 0 | (2) | |
| Net loss available to common stockholders, diluted: | (1) | (1) | (2) | (2) | (2) | (2) | (1) | |
Comprehensive Income ($ in millions)
| 12/31/2019 Q4 | 9/30/2019 Q3 | 6/30/2019 Q2 | 3/31/2019 Q1 | 12/31/2018 Q4 | 9/30/2018 Q3 | 6/30/2018 Q2 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (2) | (1) | (3) | (2) | (5) | (0) | (0) | |
| Comprehensive loss: | (2) | (1) | (3) | (2) | (5) | (0) | (0) | |
| Comprehensive income (loss), net of tax, attributable to noncontrolling interest | 1 | 1 | 2 | 2 | 11 | (2) | 1 | |
| Comprehensive income (loss), net of tax, attributable to parent: | (0) | 0 | (1) | (1) | 5 | (2) | 1 | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.